Suanfarma Overview
- Year Founded
-
1993
- Status
-
Private
- Employees
-
475
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
5
Suanfarma General Information
Description
Operator of a life sciences company intended for the pharmaceutical, veterinary and nutritional industries. The company offers a wide range of intermediate products, active ingredients for human health and veterinary as well as nutritional ingredients, enabling clients to procure customized products needed for all the phases of drug development.
Contact Information
Website
www.suanfarma.comCorporate Office
- Calle de Einstein 8
- Alcobendas
- 28108 Madrid
- Spain
Corporate Office
- Calle de Einstein 8
- Alcobendas
- 28108 Madrid
- Spain
Suanfarma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Suanfarma Comparisons
Industry
Financing
Details
Suanfarma Competitors (3)
One of Suanfarma’s 3 competitors is Arevipharma, a Corporate Backed or Acquired company based in Radebeul, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arevipharma | Corporate Backed or Acquired | Radebeul, Germany | ||||
| CPL SACHSE | Corporation | Berlin, Germany | ||||
| Procyon Life Sciences | Corporation | Mumbai, India |
Suanfarma Signals
Suanfarma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Suanfarma Investments & Acquisitions (5)
Suanfarma’s most recent deal was a Buyout/LBO with Monteloeder. The deal was made on 11-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Monteloeder | 11-Feb-2022 | Buyout/LBO | Biotechnology | ||
| Gonmisol | 01-Jan-2017 | Buyout/LBO | Distributors/Wholesale | ||
| Companhia Industrial Productora de Antibioticos | 24-Oct-2016 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Idifarma Desarrollo Farmacéutico | 10-Sep-2016 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology | ||
| CIDQO | 07-Mar-2013 | Merger/Acquisition | Laboratory Services (Healthcare) |
Suanfarma Exits (1)
Suanfarma’s most recent exit was on 10-Sep-2016 from Idifarma Desarrollo Farmacéutico. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Idifarma Desarrollo Farmacéutico | 10-Sep-2016 | Completed |
|
Suanfarma Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CIDQO | Barcelona, Spain | 2012 | |
| Gonmisol | Barcelona, Spain | 1963 | |
| Companhia Industrial Productora de Antibioticos | Carregado, Portugal | 1960 |
Suanfarma FAQs
-
When was Suanfarma founded?
Suanfarma was founded in 1993.
-
Where is Suanfarma headquartered?
Suanfarma is headquartered in Madrid, Spain.
-
What is the size of Suanfarma?
Suanfarma has 475 total employees.
-
What industry is Suanfarma in?
Suanfarma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Suanfarma a private or public company?
Suanfarma is a Private company.
-
What is the current valuation of Suanfarma?
The current valuation of Suanfarma is .
-
What is Suanfarma’s current revenue?
The current revenue for Suanfarma is .
-
Who are Suanfarma’s investors?
ARCHIMED and Ares Management have invested in Suanfarma.
-
Who are Suanfarma’s competitors?
Arevipharma, CPL SACHSE, and Procyon Life Sciences are competitors of Suanfarma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process